These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6752179)

  • 1. T cells and immunoregulation: a contemporary overview.
    Goldstein G
    J Clin Immunol; 1982 Jul; 2(3 Suppl):5S-7S. PubMed ID: 6752179
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical-induced immunomodulation.
    Koller LD
    J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methodological problems of screening immunotropic agents].
    Uteshev BS
    Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principle of immunoregulation in the treatment of chronic inflammatory rheumatism].
    Duţu A; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(3):193-203. PubMed ID: 6084276
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulatory agents in the laboratory and clinic.
    Nüssler AK; Thomson AW
    Parasitology; 1992; 105 Suppl():S5-23. PubMed ID: 1308930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 antibody as an adjuvant induces enhanced T cell responses.
    Carlring J; Barr TA; McCormick AL; Heath AW
    Vaccine; 2004 Sep; 22(25-26):3323-8. PubMed ID: 15308355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacological stimulation of immunity].
    Alekhin EK; Lazareva DN
    Eksp Klin Farmakol; 1994; 57(4):3-6. PubMed ID: 7950779
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
    Palacios R
    J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.
    Hardy B; Kovjazin R; Raiter A; Ganor N; Novogrodsky A
    Hum Antibodies; 1997; 8(2):95-8. PubMed ID: 9289394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 13. Short- and long-term effects of T-cell modulating agents in experimental autoimmunity.
    Mellergård J; Havarinasab S; Hultman P
    Toxicology; 2004 Mar; 196(3):197-209. PubMed ID: 15036746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of syngeneic and xenogeneic apolipoprotein B-containing lipoproteids on the immune response and phagocytosis in mice].
    Belokrylov GA; Popova OIa; Bondar' KB; Denisenko AD
    Biull Eksp Biol Med; 1998 Mar; 125(3):293-6. PubMed ID: 9606547
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Therapeutic potential of targeting BTLA.
    Crawford A; Wherry EJ
    J Leukoc Biol; 2009 Jul; 86(1):5-8. PubMed ID: 19567411
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic therapy: the immunopharmacology of biological and genetic manipulations].
    Baudrihaye MF
    J Pharm Belg; 1988; 43(4):330-4. PubMed ID: 3070006
    [No Abstract]   [Full Text] [Related]  

  • 17. An anti-CD2 monoclonal antibody that elicits alloantigen-specific hyporesponsiveness.
    Schad V; Greenstein JL; Giovino-Barry V; LeGuern A; Matejic T; Glaser R; Dickerson M; Xu Y; Bazin H; Latinne D; Monroy R; White-Scharf ME
    Transplant Proc; 1996 Aug; 28(4):2051-3. PubMed ID: 8769152
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
    Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-T cell monoclonal antibodies for immunosuppression in xenotransplantation of fetal pig pancreas in NOD mice.
    Mandel TE; Koulmanda M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):796-7. PubMed ID: 8438485
    [No Abstract]   [Full Text] [Related]  

  • 20. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.